The mitochondrial isoforms of folate cycle enzymes serine hydroxymethyl transferase and methylene-tetrahydrofolate reductase (SHMT2 and MTHFD2) are very important targets for drug development in cancer therapy [80]. Here, MTHFD2 is linked to cancer.